SPARC and colorectal carcinoma: The wound healing assay showed that compared with the control, the hsa-miR-29c-3p mimic and si-SPARC inhibited CRC cell migration capability, while the hsa-miR-29c-3p inhibitor enhanced it (Figure 10D, 10F, 10E, 10G).